#BreakingNews: Lilly has submitted a request for Emergency Use Authorization for one of our potential #COVID19 antibody treatments to @US_FDA. Learn more about the supporting data and progress of our potential combination antibody therapy treatment: https://t.co/caWgR4YHzz pic.twitter.com/rpU3fmIif6— Eli Lilly and Company (@LillyPad) October 7, 2020
#BreakingNews: Lilly has submitted a request for Emergency Use Authorization for one of our potential #COVID19 antibody treatments to @US_FDA. Learn more about the supporting data and progress of our potential combination antibody therapy treatment: https://t.co/caWgR4YHzz pic.twitter.com/rpU3fmIif6